Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 8

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 8
---
, or the perception that such sales may occur, could adversely affect the price of our common stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares of common stock for sale will have on the market price of our common stock.

There is no public market for the Pre-funded Warrants or the Warrants being offered in this offering.

There is no established public trading market for the Pre-funded Warrants or the Warrants being offered in this offering, and we do not expect a market to develop. In addition, we do not intend to apply to list the Pre-funded Warrants or the Warrants on any national securities exchange or other nationally recognized trading system, including the Nasdaq Capital Market. Without an active market, the liquidity of the Pre-funded Warrants or the Warrants will be limited.

| S-4 |

Holders of our Pre-funded Warrants and Warrants will have no rights as a common stockholder until they acquire our common stock.

Until you acquire shares of our common stock upon exercise of the Pre-funded Warrants or the Warrants, you will have no rights with respect to shares of our common stock issuable upon exercise of the Pre-funded Warrants or the Warrants. Upon exercise of your Pre-funded Warrants or Warrants, you will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after the exercise date.

The Pre-funded Warrants and the Warrants are speculative in nature.

The Pre-funded Warrants and the Warrants offered hereby do not confer any rights of common stock ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire shares of common stock at a fixed price. Specifically, commencing on the date of issuance, holders of the Pre-funded Warrants may acquire the common stock issuable upon exercise of such Warrants at an exercise price of $0.0001 per share and holders of the Warrants may acquire the common stock issuable upon exercise of such Warrants at an exercise price of $3.482 per share. Moreover, following this offering, the market value of the Pre-funded Warrants and the Warrants is uncertain and there can be no assurance that the market value of the Pre-funded Warrants and the Warrants will equal or exceed their offering price. There can be no assurance that the market price of the common stock will ever equal or exceed the exercise price of the Warrants and consequently, whether